Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

12 Dec 2025
// EXPRESSPHARMA
https://www.expresspharma.in/senores-pharmaceuticals-launches-deferiprone-tablets-usp-in-the-u-s/

05 Dec 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/drug-approval/senores-pharmaceuticals-receives-philippine-fda-approval-for-10-products-18469

06 Nov 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/news/senores-pharma-forms-new-subsidiary-in-us-18154

14 Aug 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/news/senores-pharmaceuticals-acquires-andas-from-teva-pharmaceuticals-usa-17597

12 Jul 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/news/senores-pharmaceuticals-to-increase-stake-in-havix-17402

22 May 2025
// EXPRESS PHARMA
https://www.expresspharma.in/senores-pharmaceuticals-gains-anda-for-enalapril-maleate-tablets-2-5mg-5mg-10mg-and-20mg-from-wockhardt/
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

About the Company : Senores Pharmaceuticals is a thought-leading pharmaceutical company all set to leave its footprints in the global market. We at Senores Pharmaceuticals are committed to innovate and manufacture ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

About the Company : Senores Pharmaceuticals is a thought-leading pharmaceutical company all set to leave its footprints in the global market. We at Senores Pharmaceuticals are committed to innovate and manufacture ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

About the Company : Senores Pharmaceuticals is a thought-leading pharmaceutical company all set to leave its footprints in the global market. We at Senores Pharmaceuticals are committed to innovate and manufacture ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

About the Company : Senores Pharmaceuticals is a thought-leading pharmaceutical company all set to leave its footprints in the global market. We at Senores Pharmaceuticals are committed to innovate and manufacture ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

About the Company : Senores Pharmaceuticals is a thought-leading pharmaceutical company all set to leave its footprints in the global market. We at Senores Pharmaceuticals are committed to innovate and manufacture ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

About the Company : Senores Pharmaceuticals is a thought-leading pharmaceutical company all set to leave its footprints in the global market. We at Senores Pharmaceuticals are committed to innovate and manufacture ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

About the Company : Senores Pharmaceuticals is a thought-leading pharmaceutical company all set to leave its footprints in the global market. We at Senores Pharmaceuticals are committed to innovate and manufacture ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

About the Company : Senores Pharmaceuticals is a thought-leading pharmaceutical company all set to leave its footprints in the global market. We at Senores Pharmaceuticals are committed to innovate and manufacture ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

About the Company : Senores Pharmaceuticals is a thought-leading pharmaceutical company all set to leave its footprints in the global market. We at Senores Pharmaceuticals are committed to innovate and manufacture ...

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

About the Company : Senores Pharmaceuticals is a thought-leading pharmaceutical company all set to leave its footprints in the global market. We at Senores Pharmaceuticals are committed to innovate and manufacture ...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Senores will acquire the USFDA-approved Abbreviated New Drug Application (ANDA) for Topiramate HCl from Wockhardt, indicated as a treatment of epilepsy and migraine.
Lead Product(s): Topiramate HCl,Inapplicable
Therapeutic Area: Neurology Brand Name: Topiramate-Generic
Study Phase: Approved FDFProduct Type: Miscellaneous
Recipient: Wockhardt
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition May 06, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Topiramate HCl,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Recipient : Wockhardt
Deal Size : Undisclosed
Deal Type : Acquisition
Senores Pharmaceuticals acquires ANDA for Topiramate HCl 25, 50, 100 and 200 mg tablets
Details : Senores will acquire the USFDA-approved Abbreviated New Drug Application (ANDA) for Topiramate HCl from Wockhardt, indicated as a treatment of epilepsy and migraine.
Product Name : Topiramate-Generic
Product Type : Miscellaneous
Upfront Cash : Undisclosed
May 06, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Senores acquire the USFDA-approved abbreviated new drug application for Roflumilast, indicated as a treatment to reduce the risk of COPD exacerbations, from Breckenridge.
Lead Product(s): Roflumilast,Inapplicable
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Roflumilast-Generic
Study Phase: Approved FDFProduct Type: Miscellaneous
Recipient: Breckenridge Pharmaceutical
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition February 21, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Roflumilast,Inapplicable
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Approved FDF
Recipient : Breckenridge Pharmaceutical
Deal Size : Undisclosed
Deal Type : Acquisition
Senores Pharma Gains After Arm Inks Pact to Acquire Roflumilast Tablets
Details : Senores acquire the USFDA-approved abbreviated new drug application for Roflumilast, indicated as a treatment to reduce the risk of COPD exacerbations, from Breckenridge.
Product Name : Roflumilast-Generic
Product Type : Miscellaneous
Upfront Cash : Undisclosed
February 21, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
A combination tablet of metoprolol tartrate, a beta adrenoceptor blocker, and hydrochlorothiazide, a thiazide diuretic, has been approved for hypertension.
Lead Product(s): Metoprolol Tartrate,Hydrochlorothiazide
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 10, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Metoprolol Tartrate,Hydrochlorothiazide
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Senores Pharma Gets Final Approval for Metoprolol Tartrate and Hydrochlorothiazide Tablets
Details : A combination tablet of metoprolol tartrate, a beta adrenoceptor blocker, and hydrochlorothiazide, a thiazide diuretic, has been approved for hypertension.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 10, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Stromectol-Generic (ivermectin) is a glutamate-gated chloride channel modulator, small molecule drug candidate, which is indicated for the treatment of patients with strongyloidiasis & onchocerciasis.
Lead Product(s): Ivermectin,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Stromectol-Generic
Study Phase: Approved FDFProduct Type: Miscellaneous
Recipient: Dr. Reddy\'s Laboratories
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 26, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ivermectin,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Recipient : Dr. Reddy\'s Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Dr. Reddy's Laboratories and Senores Pharmaceuticals Launch Ivermectin Tablets in US
Details : Stromectol-Generic (ivermectin) is a glutamate-gated chloride channel modulator, small molecule drug candidate, which is indicated for the treatment of patients with strongyloidiasis & onchocerciasis.
Product Name : Stromectol-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 26, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Nicardipine Hydrochloride Capsules is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible.
Lead Product(s): Nicardipine Hydrochloride,Inapplicable
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Nicardipine Hydrochloride-Generic
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 25, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Nicardipine Hydrochloride,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Nicardipine Hydrochloride Capsules is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible.
Product Name : Nicardipine Hydrochloride-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 25, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg, a therapeutic equivalent of reference listed drug Butalbital, Acetaminophen, and Caffeine capsules of Mayne Pharma, indicated for relief of symptom complex of tension (or muscle contraction) headache.
Lead Product(s): Butalbital,Paracetamol,Caffeine
Therapeutic Area: Neurology Brand Name: Butalbital-Generic
Study Phase: Approved FDFProduct Type: Controlled Substance
Recipient: Seton Pharmaceuticals
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 17, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Butalbital,Paracetamol,Caffeine
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Recipient : Seton Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg, a therapeutic equivalent of reference listed drug Butalbital, Acetaminophen, and Caffeine capsules of Mayne Pharma, indicated for relief of symptom complex of tension (or muscle con...
Product Name : Butalbital-Generic
Product Type : Controlled Substance
Upfront Cash : Inapplicable
March 17, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Chlorzoxazone Tablets USP, 250 mg, a therapeutic equivalent version of Paraflex (Chlorzoxazone) is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.
Lead Product(s): Chlorzoxazone,Inapplicable
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: Approved FDFProduct Type: Miscellaneous
Recipient: Cintex
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 05, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Chlorzoxazone,Inapplicable
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Recipient : Cintex
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Chlorzoxazone Tablets USP, 250 mg, a therapeutic equivalent version of Paraflex (Chlorzoxazone) is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal condition...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 05, 2021

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BUTALBITAL AND ACETAMINOP...
Dosage Strength : 300MG;50MG
Packaging :
Approval Date : 2022-04-07
Application Number : 214088
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BUTALBITAL AND ACETAMINOP...
Dosage Strength : 325MG;25MG
Packaging :
Approval Date : 2022-04-07
Application Number : 214088
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BUTALBITAL AND ACETAMINOP...
Dosage Strength : 325MG;50MG
Packaging :
Approval Date : 2022-04-07
Application Number : 214088
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Dosage Form : CAPSULE;ORAL
Brand Name : BUTALBITAL, ACETAMINOPHEN...
Dosage Strength : 300MG;50MG;40MG
Packaging :
Approval Date : 2021-08-13
Application Number : 214087
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Dosage Form : CAPSULE;ORAL
Brand Name : BUTALBITAL, ACETAMINOPHEN...
Dosage Strength : 325MG;50MG;40MG
Packaging :
Approval Date : 2021-08-13
Application Number : 214087
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMPHETAMINE SULFATE
Dosage Strength : 5MG
Packaging :
Approval Date : 2020-05-22
Application Number : 212901
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMPHETAMINE SULFATE
Dosage Strength : 10MG
Packaging :
Approval Date : 2020-05-22
Application Number : 212901
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : LOTION;TOPICAL
Brand Name : BETAMETHASONE VALERATE
Dosage Strength : EQ 0.1% BASE
Packaging :
Approval Date : 1985-07-31
Application Number : 70052
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : CARBINOXAMINE MALEATE
Dosage Strength : 4MG
Packaging :
Approval Date : 2010-04-15
Application Number : 90435
Regulatory Info : DISCN
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : CHLORZOXAZONE
Dosage Strength : 250MG
Packaging :
Approval Date : 2021-07-29
Application Number : 215158
Regulatory Info : RX
Registration Country : USA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
Senores Pharmaceuticals is a supplier offers 13 products (APIs, Excipients or Intermediates).
Find a price of Aripiprazole bulk offered by Senores Pharmaceuticals
Find a price of Benfotiamine bulk offered by Senores Pharmaceuticals
Find a price of Clomiphene Citrate bulk offered by Senores Pharmaceuticals
Find a price of Desloratadine bulk offered by Senores Pharmaceuticals
Find a price of Desvenlafaxine Succinate bulk offered by Senores Pharmaceuticals
Find a price of Fluoxetine Hydrochloride bulk offered by Senores Pharmaceuticals
Find a price of Imatinib Mesylate bulk offered by Senores Pharmaceuticals
Find a price of Letrozole bulk offered by Senores Pharmaceuticals
Find a price of Mesalazine bulk offered by Senores Pharmaceuticals
Find a price of Nicardipine Hydrochloride bulk offered by Senores Pharmaceuticals
Find a price of Oxcarbazepine bulk offered by Senores Pharmaceuticals
Find a price of Rivaroxaban bulk offered by Senores Pharmaceuticals
Find a price of Tamsulosin bulk offered by Senores Pharmaceuticals